Luye Pharma to spin off Singapore unit in $500m listing

healthcare px230
By John Loh
28 Feb 2018

Luye Medical, the healthcare services arm of Luye Life Sciences Group, has enlisted three banks to lead its IPO of about $500m in Singapore.

Bank of America Merrill Lynch, Credit Suisse and UBS are working towards launching the transaction towards the end of the year, said a banker close to the situation.

Singapore-headquartered Luye Medical is a unit of Hong Kong-listed drug manufacturer Luye Pharma Group.

The issuer, founded in 2015, has embarked ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial